Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Receivables Turnover : 1.45 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Revenue for the three months ended in Mar. 2025 was ¥52.2 Mil. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥35.9 Mil. Hence, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover for the three months ended in Mar. 2025 was 1.45.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Receivables Turnover Historical Data

The historical data trend for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Receivables Turnover Chart

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data

Trend

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

7.79

7.94

7.01

7.04

7.89

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Receivables Turnover	Get a 7-Day Free Trial															1.97	1.64	1.71	1.71	1.45

Competitive Comparison of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	256.405	/ (	(28.287	+	36.733)	/	2 )
=	256.405	/	32.51
=	7.89

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

	Receivables Turnover (Q: Mar. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2025 )	/ (	(Accounts Receivable (Q: Dec. 2024 )	+	Accounts Receivable (Q: Mar. 2025 ))	/	count )
=	52.219	/ (	(36.733	+	35.134)	/	2 )
=	52.219	/	35.9335
=	1.45

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » Receivables Turnover

Traded in Other Exchanges

N/A

Address

No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300

Website

http://www.xidianyy.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines